How breast cancer drugs exploit genomic fractures in tumors
A new study from WashU Medicine researchers identifies possible ways to make cancer drugs called PARP inhibitors more effective, including potential strategies to re-establish their effectiveness in tumors that develop resistance to this treatment.
Tsuyoshi Kaneko, MD, a clinical innovator who has developed new devices and techniques for heart valve surgeries, has been named the new director of the Division of Cardiothoracic Surgery in the Department of Surgery at WashU Medicine.
Over the next several weeks, the 1,970 members of the Class of 2029 will learn more about WashU’s academic resources, student groups and boba tea options. But during move in, WashU resident advisors, WashU Student Associates and student leaders have one goal: to make every new student feel at home.
